{"id":1063135,"date":"2011-12-11T16:54:39","date_gmt":"2011-12-11T16:54:39","guid":{"rendered":"http:\/\/www.longevitymedicine.tv\/california-stem-cell-agency-approves-27-million-to-hasten-stem-cell-therapies\/"},"modified":"2024-08-17T20:27:19","modified_gmt":"2024-08-18T00:27:19","slug":"california-stem-cell-agency-approves-27-million-to-hasten-stem-cell-therapies-2","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/california-stem-cell-agency-approves-27-million-to-hasten-stem-cell-therapies-2.php","title":{"rendered":"California Stem Cell Agency Approves $27 Million To Hasten Stem Cell Therapies"},"content":{"rendered":"

<\/a>
<\/a><\/p>

Efforts to speed development of stem cell therapies received a $27 million boost today from directors of the $3 billion California stem cell agency. <\/p>

They approved two initiatives that grew out of recommendations from a blue-ribbon panel that CIRM organized last year to review its operations.<\/p>

One element in the plan is a $12 million \"bridging fund\" that would apply only to current CIRM<\/b>-funded projects in three areas: disease team grants, some early translational projects and clinical development projects. The bridging fund would provide up to $3 million for up to one year for each recipient.<\/p>

As originally proposed by CIRM staff, CIRM President Alan Trounson<\/b> would have been authorized to approve each project. However, the board altered that process to require board approval with \"peer review input.\"<\/p>

Director Shlomo Melmed<\/b>, a senior vice president at Cedars-Sinai<\/b> in Los Angeles, argued that leaving the decision to Trounson and staff could place Trounson in an \"untenable\" position and lead to second-guessing. Melmed and others also said that process could open the agency to public criticism. <\/p>

Trounson and other staff members said that biotech firms often need speedier action than can be provided by a more extended process. Director Jonathan Shestack<\/b>, a Hollywood producer, agreed, but he was the lone vote to oppose removing the authority from Trounson.<\/p>

No biotech companies spoke out at the meeting concerning the proposal (see here for an earlier version <\/a>of the plan).<\/p>

The second part of the response to the review panel's finding is a $15 million \"external innovation initiative\"<\/a> to support collaborative efforts of CIRM grantees to work with teams that CIRM said are \"making extraordinary progress outside California.\"<\/p>

The $15 million program would provide awards as often as two times a year. The maximum amount on each award was not specified. The program was approved on a unanimous voice vote. <\/p>

Ellen Feigal<\/b>, CIRM's vice president of research and development, said in a memo to directors that examples of potential projects included collaborative efforts with the NIH<\/b> and work with the Harvard Stem Cell Institute<\/b> and its disease-focused programs. CIRM is planning to spend $300,000 over two years in work with the NIH. <\/p>

Some of the latest CIRM initiatives are open to biotech businesses. Others are open only to non-profit or academic researchers.<\/p>

\"\"<\/div>

Source:
http:\/\/californiastemcellreport.blogspot.com\/feeds\/posts\/default?alt=rss<\/a><\/p>","protected":false},"excerpt":{"rendered":"

Efforts to speed development of stem cell therapies received a $27 million boost today from directors of the $3 billion California stem cell agency. They approved two initiatives that grew out of recommendations from a blue-ribbon panel that CIRM organized … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[25,1246878],"tags":[],"class_list":["post-1063135","post","type-post","status-publish","format-standard","hentry","category-stem-cell-therapy","category-stem-cells"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1063135"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1063135"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1063135\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1063135"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1063135"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1063135"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}